Mark S. Blumenkranz, CEO & Chairman
By FLG Partners
“I’ve had the fortunate opportunity to work closely with Mark Murray of FLG Partners in a series of four successful venture backed -backed companies in Silicon Valley over the past dozen years including Optimedica Corporation (acquired by Abbott), Oculeve (acquired by Allergan), Oyster Point Pharmaceuticals (IPO) and most recently Kedalion Therapeutics (acquired by Novartis)….Read More
Read MoreMarcel Roche, CFO
By FLG Partners
“We were seeking consulting in our finance function for long-term planning, financing, and reporting. We hired Patrick Nugent at FLG and he couldn’t have been a better choice. Patrick was able to provide effective frameworks and best practices, leverage his network and expertise in the industry, and engage cross-functionally. As…Read More
Read More